Scheme

Tata Nifty MidSmall Healthcare Index Fund

Holds 30 companies worth ₹221 Cr in Sept 2026.

Fund house
TataThe fund house that runs this scheme.
AUM
₹221 CrTata Nifty MidSmall Healthcare Index Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Up 0.7% on Aug 2026, ₹219 Cr.
Largest holding
Laurus Labs LimitedLaurus Labs Limited is 11.8% of this scheme's NAV.
Fund manager
Nitin SharmaRuns it since 1 Jul 2025, as the fund house dates it. With Rakesh Prajapati (co-manager).

Holdings^{(Apr 2024 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	30 companies ·	₹ Cr
	Laurus Labs Limited	26.1
	Lupin	16.7
	Aurobindo Pharma	15.7
	Fortis Healthcare Limited	13.6
	Glenmark Pharmaceuticals	11.9
	Alkem Laboratories Limited	10.6
	Mankind Pharma Limited	9.6
	IPCA Laboratories Limited	9.1
	Biocon	8.7
	Gland Pharma Limited	7.8
	Sai Life Sciences Limited	7.1
	Krishna Institute of Medical Science Ltd	6.8
	Aster DM Healthcare Limited	6.3
	Neuland Laboratories Limited	6.2
	Wockhardt	5.9
	Acutaas Chemicals Limited	5.8
	Ajanta Pharmaceuticals Limited	5.6
	Dr Lal Path Labs Limited	5.3
	Abbott India Limited	4.8
	Piramal Pharma Limited	4.4
	Granules India Limited	4.2
	Narayana Hrudayalaya Limited	4.2
	Global Health Limited	4.1
	Onesource Speciality Pharma Ltd	4.1
	GLAXO SMITHKLINE PHARMA	3.9
	Anthem Biosciences Limited	3.1
	Natco Pharma	2.5
	Cohance Lifesciences Limited	2.5
	Syngene International Limited	2.4
	Poly Medicure Limited	2.2

Laurus Labs Limited
Lupin

Market value of each ticked company in Tata Nifty MidSmall Healthcare Index Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Laurus Labs Limited	Lupin
Sept 2025	₹9.8 Cr	₹13.8 Cr
Oct 2025	₹11.1 Cr	₹14.2 Cr
Nov 2025	₹12 Cr	₹15.1 Cr
Dec 2025	₹12.7 Cr	₹15.1 Cr
Jan 2026	₹11 Cr	₹15.3 Cr
Feb 2026	₹12.4 Cr	₹16.5 Cr
Mar 2026	₹11.2 Cr	₹16.3 Cr
Apr 2026	₹12.4 Cr	₹16.2 Cr
May 2026	₹15.3 Cr	₹15.9 Cr
Jun 2026	₹17.1 Cr	₹16.9 Cr
Jul 2026	₹22.3 Cr	₹18.5 Cr
Aug 2026	₹24.6 Cr	₹17.5 Cr
Sept 2026	₹26.1 Cr	₹16.7 Cr

Fig. 1.Market value of each ticked company in Tata Nifty MidSmall Healthcare Index Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Mid Cap	15	67.91

Small Cap	15	32.23

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Laurus Labs Limited	Equity	Pharmaceuticals & Biotechnology	1.32L	26.1	11.84
Lupin	Equity	Pharmaceuticals & Biotechnology	82.3K	16.7	7.57
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	93.6K	15.7	7.09
Fortis Healthcare Limited	Equity	Healthcare Services	1.76L	13.6	6.16
Glenmark Pharmaceuticals	Equity	Pharmaceuticals & Biotechnology	51K	11.9	5.40
Alkem Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	20.4K	10.6	4.78
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	38.4K	9.6	4.36
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	47.1K	9.1	4.11
Biocon	Equity	Pharmaceuticals & Biotechnology	2.36L	8.7	3.96
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	27K	7.8	3.55
Sai Life Sciences Limited	Equity	Pharmaceuticals & Biotechnology	46.9K	7.1	3.24
Krishna Institute of Medical Science Ltd	Equity	Healthcare Services	90.4K	6.8	3.06
Aster DM Healthcare Limited	Equity	Healthcare Services	90.5K	6.3	2.86
Neuland Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	2.92K	6.2	2.83
Wockhardt	Equity	Pharmaceuticals & Biotechnology	28K	5.9	2.68
Acutaas Chemicals Limited	Equity	Pharmaceuticals & Biotechnology	17.6K	5.8	2.61
Ajanta Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	15.4K	5.6	2.53
Dr Lal Path Labs Limited	Equity	Healthcare Services	26.4K	5.3	2.38
Abbott India Limited	Equity	Pharmaceuticals & Biotechnology	1.77K	4.8	2.17
Piramal Pharma Limited	Equity	Pharmaceuticals & Biotechnology	2.1L	4.4	1.97
Granules India Limited	Equity	Pharmaceuticals & Biotechnology	50K	4.2	1.92
Narayana Hrudayalaya Limited	Equity	Healthcare Services	23.4K	4.2	1.90
Global Health Limited	Equity	Healthcare Services	30K	4.1	1.86
Onesource Speciality Pharma Ltd	Equity	Pharmaceuticals & Biotechnology	26.7K	4.1	1.84
GLAXO SMITHKLINE PHARMA	Equity	Pharmaceuticals & Biotechnology	14K	3.9	1.76
Anthem Biosciences Limited	Equity	Pharmaceuticals & Biotechnology	36.6K	3.1	1.42
Natco Pharma	Equity	Pharmaceuticals & Biotechnology	30.4K	2.5	1.14
Cohance Lifesciences Limited	Equity	Pharmaceuticals & Biotechnology	55.1K	2.5	1.11
Syngene International Limited	Equity	Healthcare Services	64.3K	2.4	1.06
Poly Medicure Limited	Equity	Healthcare Equipment & Supplies	12.9K	2.2	0.98

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.